Back to Results
First PageMeta Content
Pediatrics / Lipid storage disorders / Medical genetics / Lysosomal storage disease / Newborn screening / Inborn error of metabolism / Genetic disorder / Cystic fibrosis / Enzyme replacement therapy / Health / Medicine / Rare diseases


Microsoft Word - Document1
Add to Reading List

Document Date: 2014-12-04 01:13:21

Open Document

File Size: 35,47 KB

Share Result on Facebook

City

Waltham / /

Company

President & CEO LysoPlex LLC / LysoPlex LLC / LSDs / /

Country

United States / /

IndustryTerm

therapies for patients with lysosomal-storage diseases / biotechnology / biotechnology industry / multiplex technology / curative technologies / /

MedicalCondition

lysosomal-storage diseases / certain diseases / classically screened diseases / severe mental retardation / genetic diseases / diseases / lysosomal storage diseases / inborn errors of metabolism / cystic fibrosis / /

MedicalTreatment

gene therapy / enzyme replacement therapy / bone marrow transplant / /

Organization

Federal Government / Food and Drug Administration / Advisory Committee on Heritable Disorders and Genetic Diseases / /

Person

Anthony A. McKinney / John Hopwood / /

Position

Professor / forward a novel multiplex technology / /

Product

penicillin / /

ProvinceOrState

Massachusetts / /

Technology

gene therapy / biomaterials / biotechnology / /

SocialTag